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Aquaporin-4 (AQP4) is expressed in astrocytes throughout the central nervous system, particularly at the blood–brain and brain–cerebrospinal
fluid barriers. Phenotype analysis of transgenic mice lacking AQP4 has provided compelling evidence for involvement of AQP4 in cerebral water
balance, astrocyte migration, and neural signal transduction. AQP4-null mice have reduced brain swelling and improved neurological outcome in
models of (cellular) cytotoxic cerebral edema including water intoxication, focal cerebral ischemia, and bacterial meningitis. However, brain
swelling and clinical outcome are worse in AQP4-null mice in models of vasogenic (fluid leak) edema including cortical freeze-injury, brain
tumor, brain abscess and hydrocephalus, probably due to impaired AQP4-dependent brain water clearance. AQP4 deficiency or knock-down
slows astrocyte migration in response to a chemotactic stimulus in vitro, and AQP4 deletion impairs glial scar progression following injury in
vivo. AQP4-null mice also manifest reduced sound- and light-evoked potentials, and increased threshold and prolonged duration of induced
seizures. Impaired K+ reuptake by astrocytes in AQP4 deficiency may account for the neural signal transduction phenotype. Based on these
findings, we propose modulation of AQP4 expression or function as a novel therapeutic strategy for a variety of cerebral disorders including
stroke, tumor, infection, hydrocephalus, epilepsy, and traumatic brain injury.
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Excess accumulation of brain water, cerebral edema, is of
central importance in the pathophysiology of a wide range of
central nervous system (CNS) abnormalities such as stroke,
tumor, infection, hydrocephalus, and traumatic brain injury [1].
Cerebral edema produces elevated intracranial pressure (ICP),
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Despite a large body of empirical data on brain edema and its
causes and consequences, current treatments for brain edema
such as hyperosmolar agents and surgical decompression have
changed little since their introduction more than 80 years ago
[2].
Aquaporin-4 (AQP4) is a water-selective transporter origi-
nally cloned by our lab in 1994 from lung tissue [3] and shown to
be expressed strongly in brain [4]. AQP4 is expressed in
astrocytes and ependymal cells throughout the brain and spinal
cord, particularly at sites of fluid transport at the pial and
ependymal surfaces in contact with the cerebrospinal fluid (CSF)
in the subarachnoid space and the ventricular system (Fig. 1)
[5,6]. Polarized AQP4 expression is found in astrocytic foot
processes in direct contact with blood vessels. In spinal cord,
AQP4 expression is high in gray matter where numerous AQP4
dense processes are found in direct contact with neuronal cell
bodies and synapses [7,8]. This expression pattern suggests
AQP4 involvement in the movement of water between blood
and brain, and between brain and CSF compartments. Interest-
ingly, AQP4 is a structural component of membrane orthogonal
arrays of particles (OAPs), which are regularly spaced
intramembrane particles seen in freeze-fracture electron micro-
graphs (FFEM). Based on AQP4 expression in the same cells in
which OAPs were identified, we originally proposed that AQP4
is the OAP protein [9]. Support for this hypothesis came from
FFEM on stably transfected CHO cells [10], and from the
absence of orthogonal arrays in brain, kidney and skeletal
muscle from AQP4-null mice [11].
This review is focused on the role of AQP4 in brain function,
as deduced largely from phenotype analysis of transgenic mice
deficient in AQP4. These mice, originally generated by targetedFig. 1. Schematic showing site of AQP4 expression in brain and threegene disruption in 1997 and shown to have only a very mild
urinary concentrating defect [12], have normal brain structure,
vascular anatomy, baseline ICP, intracranial compliance, and
blood–brain barrier function [13,14]. We review evidence for
involvement of AQP4 in cytotoxic brain edema, as well as in
several unanticipated functions, including vasogenic brain
edema, glial cell migration, and neural signal transduction.
2. Involvement of AQP4 in brain edema
The two main types of cerebral edema are cellular (cytotoxic)
and vasogenic [15]. Cellular edema occurs when fluid flows
from the vascular compartment, through intact blood–brain
barrier and astrocytic foot processes, and accumulates primarily
in astrocytes [16]. In vasogenic edema, the blood–brain barrier
becomes leaky, permitting the entry of plasma fluid into the
brain ECS. Edema fluid is eliminated from the brain through
the glia limitans externa into the subarachnoid space, through
the glia limitans interna and ependyma into the ventricles,
and through the blood–brain barrier into the blood [15,17,18].
Hydrocephalic edema, which is sometimes classified as a
specialized type of vasogenic brain edema [1], arises from
impaired escape of CSF into the blood by obstruction of CSF
drainage.
We initially tested the hypothesis that AQP4 plays a role in
the early accumulation of brain water in response to established
neurological insults producing cytotoxic brain edema, including
acute water intoxication [13]. Brains fromAQP4 null mice show
reduced osmotic water permeability as measured in isolated
membrane vesicles [12], brain slices [19], and intact brain [20].
Also, water permeability was seven-fold reduced in primary
astrocyte cultures from AQP4-deficient mice as measured by apathways for water movement out of brain in vasogenic edema.
Fig. 2. Reduced brain edema and improved outcome in AQP4 null mice in models of cytotoxic brain edema. (A) Survival of wildtype vs. AQP4 knockout mice after
acute water intoxication produced by intraperitoneal water injection. (B) (top) Brain sections of mice at 24 h after ischemic stroke produced by permanent middle
cerebral artery occlusion. Note midline shift and marked edema in brain from wildtype mice. (bottom) Average hemispheric enlargement expressed as a percentage
determined by image analysis of brain sections. (C) Mouse survival in a bacterial model of meningitis produced by cisternal injection of Streptococcus. From
references [13,22].
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AQP4 provides the predominant pathway for water movement in
astrocytes. AQP4 deletion in mice conferred remarkable pro-
tection from cytotoxic brain edema. The survival of AQP4 null
mice after water intoxication produced by intraperitoneal water
infusion (reducing serum Na+ to 100–105 mM) was greatly
improved (Fig. 2A), with significantly reduced swelling in
astrocytic foot processes fromAQP4 null mice. In addition, at 24
h after brain ischemia produced by permanent middle cerebral
artery occlusion (suture occlusion model) there was improved
clinical outcome and significantly reduced brain swelling (Fig.
2B). We recently studied the role of AQP4 in a bacterial me-
ningitis model of cytotoxic brain edema produced by cisternal
injection of streptococcus [22]. Mice lacking AQP4 showed
remarkably improved survival (Fig. 2C) and reduced brain water
accumulation and ICP elevation, despite comparable bacterial
load and immune response. Together, these results provide direct
functional evidence for involvement of AQP4 in cytotoxic brain
edema, and suggest the potential use of AQP4-selective inhi-
bitors to reduce brain water accumulation in cytotoxic edema.
In a subsequent study in dystrophin null (mdx) mice, which
have reduced AQP4 expression in astrocyte foot processes [23],
there was similar protection against water intoxication, though
significant differences such as death in all wildtype and mdx
mice. The differences in survival between the dystrophin nullFig. 3. Increased ICP and worse clinical outcome in AQP4 null mice with melanoma b
4 and 7 days after implantation showing similar-sized tumors in wildtype and AQP4
*P<0.001 for neurological scores, *P< 0.02 for ICP). From reference [58].mice and the AQP4-null mice may be related to baseline mor-
phological alterations found in the dystrophin null mice such as
increased blood–brain barrier permeability [24], which may
enhance the transport of water from the intravascular space
to the brain and hence worsen cerebral edema and clinical
outcome.
Because AQP4 permits bidirectional water transport, we
hypothesized that AQP4 may facilitate the removal of excess
brain water in vasogenic (non-cellular) brain edema. In support
of this hypothesis, we found markedly elevated intracranial
pressure (ICP) and brain water content in AQP4-deficient mice
after continuous slow intraparenchymal fluid infusion of isos-
molar artificial cerebrospinal fluid [14].
AQP4-dependent clearance of excess brain water in vaso-
genic brain edema was supported by data from three additional
models. In a freeze-injury model of vasogenic brain edema,
AQP4-deficient mice had worse clinical outcome, higher ICP,
and greater brain water accumulation, though comparable
blood–brain barrier leakiness (as assessed by Evans blue dye
extravasation) [14]. To investigate the clinical relevance of these
observations, we developed a model of brain tumor edema in-
volving stereotaxic implantation of melanoma cells. Melanoma
cells were injected into the right striatum as diagrammed (Fig.
3A, top). The injected cells produced a rapidly growing, well-
demarcated dark tumor in wildtype and AQP4 null micerain tumor. (A) (top) Site of injection of melanoma cells. (bottom) Tumor size at
null mice. (B) Neurological score and (C) ICP measured at 7 days (mean±S.E.,
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implantation by optical imaging of 1-mm thick sections of
formalin-fixed brain parenchyma, did not differ significantly in
wildtype vs. AQP4 null mice. However, the AQP4 null mice had
significantly worse neurological score at days 6–8 (Fig. 3B), as
well as higher ICP (Fig. 3C) [14]. Recently, in another clinically
relevant model of vasogenic brain edema, staphylococcal brain
abscess, we found significantly worse clinical outcome in the
AQP4 null mice, with greater ICP elevation and brain water
accumulation [25]. Together, these results support a novel role
for AQP4 in the resolution of vasogenic brain edema by a
transcellular route.
The involvement of AQP4 in clearance of excess brain water
is an unanticipated finding because AQP4 is water-selective.
Vasogenic edema is generally believed to be cleared primarily by
bulk flow of fluid through the extracellular space and glia
limitans into the ventricles and subarachnoid space, and to a
lesser extent through astrocyte foot processes and capillary
endothelium into the blood [15,17,18]. Another proposed but
controversial route for clearance of edema fluid is movement
from brain parenchyma into Virchow–Robin perivascular spa-
ces, which are CSF-filled spaces that communicate with the
subarachnoid space [26]. AQP4-rich astrocyte processes of the
glia limitans interna and glia limitans externa form a dense mesh
at the brain–CSF boundaries and ultrastructural studies show
that these long astrocytic processes are separated by narrow
(<20 nm) intercellular clefts and are interconnected by gap
junctions [27]. Because of the long diffusion path, the glia limi-
tans is likely a significant permeability barrier to the extracellular
flow of water and solutes. The impaired clearance of excess
brain water in AQP4 null mice in vasogenic edema suggests
that AQP4 provides a low resistance transcellular route, whichFig. 4. Accelerated progression of hydrocephalus in AQP4 null mice. (A) Coronal sec
after kaolin injection. (B) Lateral ventricle volume over 5 days following cisternal ka
of hydrocephalus. White arrows indicate fixed flows and black arrows indicate posiallows edema fluid to move across the astrocyte cell membranes
of the glia limitans into the CSF. We propose that enhanced
elimination of excess brain water through this transcellular
pathway would also accelerate the removal of associated solutes
by creating a solute concentration gradient between brain
parenchyma and CSF. Another possibility might be altered size
of processes in the glia limitans in AQP4 deficiency that reduces
fluid clearance.
We recently investigated the role of AQP4 in progression of
hydrocephalus. Hydrocephalus occurs as the result of an im-
balance between CSF production and absorption, leading to
accumulation of extraparenchymal fluid, expansion of the ven-
tricular system, and ICP elevation. Non-communicating hydro-
cephalus is caused by obstruction within the ventricular system,
such as a tumor, that prevents CSF proximal to the obstruction
from draining into the subarachnoid space where it is absorbed.
Communicating hydrocephalus results from impaired absorp-
tion of CSF despite patent CSF pathways. Both communicating
and non-communicating (obstructive) hydrocephalus may be
congenital or acquired secondary to trauma, tumor, hemorrhage,
or infection. Current primary treatment for hydrocephalus in-
volves surgical drainage and diversion of excess CSF.
Based on rat models, we developed a reproducible mouse
model of progressive obstructive hydrocephalus [28]. Injection
of kaolin into the cisterna magna resulted in CSF accumulation
and ventricular enlargement. By 5 days post-injection there was
significant expansion of the lateral, third, and fourth ventricles in
wildtype mice (Fig. 4A). Lateral ventricle volume in wild-type
mice was <0.1 mm3 prior to kaolin administration, increasing
to >5 mm3 at 7 days post-injection. Ventricular enlargement was
significantly greater in AQP4 null mice at 3 and 5 days post-
injection, but not at 1 day (Fig. 4B). ICP was measured using ations of fixed brains from wildtype (top) and AQP4 null (bottom) mice at 5 days
olin injection. (C) ICP following kaolin injection. (D) Multi-compartment model
tive direction of pressure-dependent flows. From reference [28].
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parenchyma through a small cranial burr hole. At 3 days
following kaolin injection, ICP increased by ∼12 mm Hg above
baseline in wildtype mice (Fig. 4C). Greater ICP elevation was
seen in AQP4 null mice, such that it was not possible to measure
ICP in the null mice at 5 days because of CSF leakage caused by
drilling the small burr hole required to introduce the measuring
device. Neither ventricular size nor ICP differed significantly in
wildtype vs. AQP4 null mice at 1 day post-injection, where the
brain has relatively high compliance and fluid entry into the
brain dominates over exit.
The experimental data show that AQP4 deletion in mice
accelerates the progression of obstructive hydrocephalus. As
diagrammed in Fig. 4D, a mathematical model of progressive
hydrocephalus was developed to understand the experimental
data and to model predicted effects of upregulation of AQP4
expression. The model, which is described in detail in ref. 28,
includes CSF production and drainage, as well as water transfer
among ventricular, parenchymal, capillary and venous compart-
ments. Obstructive hydrocephalus was modeled by reduction of
hydrostatically driven fluid transport from ventricle to venous
sinus, and AQP4 deletion was modeled by reduction in permea-
bility of the capillary–parenchymal and parenchymal–ventric-
ular barriers. The model accurately reproduced the greater
severity of hydrocephalus in AQP4 null vs. wild-type mice, and
predicted a much reduced severity if AQP4 expression/function
were increased.
3. Involvement of AQP4 in glial cell migration
We recently discovered a new function of AQP4 in faci-
litating astrocyte migration. The original motivation that led to
this work was the observation of strong AQP1 expression inFig. 5. Slowed migration of AQP4-deficient astroglia. (A) Left, schematic of Boyden c
chemotactic stimulus. Middle, representative photos of transwell migration assay s
before (pre) and after (post) scraping the non-migrated cells. Scale bar=100 μm. Righ
serum. (B) Left, astroglial cell migration after stab injury in vivo. Astroglial front (blu
at 3 days after stab. Arrows show direction of migration of the reactive astroglial fron
front from the edge of the stab wound at 3 days after stab injury (*P<0.001). Scaletumor microvessels. We found remarkably impaired tumor
growth in AQP1 null mice after subcutaneous or intracranial
tumor cell implantation, with reduced tumor vascularity and
extensive necrosis [29]. Although adhesion and proliferation
were similar in primary cultures of aortic endothelia from
wildtype vs. AQP1 null mice, cell migration was greatly im-
paired in AQP1-deficient cells, with abnormal vessel formation
in vitro. Stable transfection of non-endothelial cells with AQP1
or AQP4 accelerated cell migration and in vitro wound healing.
Motile AQP1-expressing cells had prominent membrane ruffles
at their leading edge with polarization of AQP1 protein to la-
mellipodia, where rapid water fluxes occur. The findings sup-
ported a fundamental role of water channels in cell migration,
which we proposed occurs in many cell types expressing aqua-
porins. In the brain, astrocyte cell migration is important in glial
scar formation [30–33]. Rapid formation of a glial scar can be
beneficial, by restoring the blood–brain barrier, preventing neu-
ronal death, and limiting influx of inflammatory cells into the
brain [34,35]. Perhaps more often glial scar formation has
deleterious effects, including inhibition of axonal sprouting in
damaged brain and spinal cord [36], and prevention of access of
drugs or genes to a lesion [37].
Two types of assays were done to study in vitro migration of
cultured astrocytes from wild-type and AQP4-null mouse brain:
‘transwell migration’ and ‘wound healing’. Using a modified
Boyden chamber containing a porous membrane filter [38],
astrocytes suspended in culture medium containing 1% serum
were introduced into the upper chamber, with the lower chamber
containing medium with 10% serum as chemoattractant. After
6 h, cells were stained and counted, and non-migrated cells
scraped off the upper surface of the filter to count migrated cells
on the bottom surface. As shown in Fig. 5A, this assay revealed
slowed migration of AQP4 null vs. wildtype astroglia. In ahamber in which cells migrate downward through a porous filter in response to a
howing Coomassie blue-stained wildtype (+/+) and AQP4 null (−/−) astroglia
t, data summary of migration experiments towards 10% serum (*P<0.001) or 1%
e line) and margin of stab injury (red line) in wildtype and AQP4 null (E) mouse
t. GFAP immunostaining (brown). Right, average distance of reactive astroglial
bars=400 μm. From reference [38].
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were wounded by scraping a strip of cells with a micropipette tip
[38]. Wound healing was also greatly slowed in astrocytes from
AQP4-deficient mice. Results similar to those in AQP4-null
astrocytes were found in astrocytes from wildtype mice after
RNAi knock-down of AQP4. Also, AQP4-null astrocytes had
fewer lamellipodia than wildtype astrocytes, which showed
AQP4 protein polarization to the leading edge of migrating
cells.
The possible involvement of AQP4 in glial scar formation in
vivo was investigated using a model of stereotactically guided
stab injury to the cerebral cortex [30,32,35,38,39]. At various
time points, reactive astrocytes were identified by their stellate
morphology after immunostaining for GFAP. We found sig-
nificantly impaired glial cell migration in AQP4 null mice, seen
as an increased margin between strongly GFAP-positive cells
and the lesion site (Fig. 5B). These results provided in vivo
evidence for AQP4-dependent astrocyte migration. Tracking of
individual wild-type vs. AQP4-deficient astrocytes in brain will
be useful in exploring further the role of AQP4 in glial cell
migration.
The importance of water fluxes across the plasma membrane
in causing localized swelling of lamellipodia has been discussed
extensively in the early literature on cell migration [40,41]. In
support of this mechanism as applied to AQP4 migration in
astrocytes, we found that the speed of astrocyte migration can
be altered by a small osmotic gradient in the extracellular me-
dium, resulting in accelerated astrocyte migration towards
hypo-osmolality. We suggest that AQP4 accelerates astrocyte
migration by increasing plasma membrane water permeability,
which in turn increases the transmembrane water fluxes that
take place during cell movement. This hypothesis could explain
the observation that AQP4 deletion slows the rapid changes in
cell shape that take place at the leading end of migrating
astrocytes. It has been suggested that the generation of osmoles
produced by rapid actin depolymerization drives the entry of
water into the leading end of migrating cells [40], possibly in
concert with transmembrane ionic movements [42,43]. The
osmotic influx of water across the plasma membrane expandsFig. 6. In vivo cortical surface photobleaching. (A) Mouse brain surface exposed to F
cortical surface after loading with FITC-dextran (inset). (B) Photobleaching apparatus
surface of the cortex using a dichroic mirror and objective lens. Emitted fluorescence
In vivo fluorescence recovery in cortex of wildtype mouse shown in comparison tothe leading end of the cell, which is followed by actin poly-
merization to stabilize the membrane protrusion [40]. It will be
useful to measure transmembrane water movement directly in
cell protrusions.
4. Involvement of AQP4 in neural signal transduction
The brain extracellular space (ECS) comprises∼20% of brain
tissue volume, consisting of a jelly-like matrix in which neurons,
glial cells, and blood vessels are embedded. The ECS contains
ions, neurotransmitters, metabolites, peptides, and extracellular
matrix molecules, forming the microenvironment for all cells in
the brain. The ECS also serves as a critical communication
channel, in which populations of neurons and glial cells interact
by specialized synaptic contacts (neuron to neuron) as well as by
extrasynaptic diffusion of ions and neurotransmitters. Commu-
nication between neurons and glia occurs via diffusible
messengers, metabolites, and ions in the ECS [44–46]. For
example, neuronal activity is associated with depolarization of
neurons and adjacent glial cells, and with increased extracellular
glutamate and K+, which can synchronize neuronal activity as
well as activate glial metabolism and signaling [47–50]. Recent
studies have also demonstrated direct synaptic contacts onto
glial cells [51,52].
We have obtained several lines of evidence for AQP4 in-
volvement in neural signal transduction from phenotype analysis
of AQP4-null mice. Based on the expression of AQP4 in sup-
portive epithelial cells adjacent to (electrically-excitable) hair
cells in rat inner ear, we investigated the involvement of AQP4 in
auditory signal transduction [53]. Auditory brainstem response
(ABR) thresholds were remarkably increased by >20 dB in
AQP4 null mice compared to wildtype mice. Also, light evoked
potentials (b-wave amplitude measured by electroretinography)
were reduced in AQP4 null mice [54], consistent with the view
that the AQP4-expressing Müller (glia-like) cells are function-
ally coupled to the transducing bipolar cells. In brain, seizure
susceptibility in response to the convulsant (GABA antagonist)
pentylenetetrazol (PTZ) was remarkably increased in AQP4-null
mice [55]. At 40 mg/kg PTZ, all wildtype mice exhibited seizureITC-dextran with dura intact following craniectomy and fluorescence imaging of
. A laser beam is modulated by an acousto-optic modulator and directed onto the
is focused through a pinhole and detected by a gated photomultiplier (PMT). (C)
aCSF and 30% glycerol in aCSF. From reference [57].
1091A.S. Verkman et al. / Biochimica et Biophysica Acta 1758 (2006) 1085–1093activity, whereas 6 out of 7 AQP4 null mice did not exhibit
seizure activity; at 50 mg/kg PTZ, both groups exhibited seizure
activity; however, the latency to generalized (tonic–clonic)
seizures was greater in AQP4 null mice. In recent studies, in vivo
EEG characterization of electrically-induced seizures following
hippocampal stimulation indicated greater threshold and re-
markably longer seizure duration in AQP4 null mice compared
to wildtype mice [56]. These phenotype observations suggested
involvement of AQP4 in neural signal transduction, which we
proposed could be related to AQP4-dependent K+ dynamics in
the ECS. We therefore developed methodologies to test the
hypothesis that ECS volume and/or K+ uptake by glial cells is
altered in AQP4 deficiency.
Evidence for an expanded ECS in AQP4 deficiency was
obtained using a surface photobleaching method to measure the
diffusion of fluorescently-labeled macromolecules [57]. ECS in
mouse brain was labeled by exposure of the intact dura to
fluorescein-dextrans (Mr 4, 70 and 500 kDa) after craniectomy
(Fig. 6A). Fluorescein-dextran diffusion was detected by fluo-
rescence recovery after laser-induced cortical photobleaching
using confocal optics, as shown in Fig. 6B. FITC-dextran diffu-
sion was slowed∼3-fold in brain ECS relative to solution (aCSF,
artificial cerebrospinal fluid) (Fig. 6C). The cortical photo-
bleaching approach was applied to problems of brain edema,
seizure initiation, and AQP4 deficiency. Cytotoxic brain edema
(produced by water intoxication) or seizure activity (produced
by convulsants) slowed diffusion by >10-fold and created dead-
space microdomains in which free diffusion was prevented. The
hindrance to diffusion was greater for the larger fluoresceinFig. 7. Evidence for impaired glial cell K+ uptake from the ECS in AQP4 deficiency
additions of NaCl (50 and 150 mM), following by additions of KCl. (C) Serial images
by pin prick. TAC-Red fluorescence is shown in pseudocolor, with increasing inte
fluorescence at single points in wild-type and AQP4 null mice (each curve from diffe
the increase (K+ release) and return to baseline (K+ reuptake) in TAC-Red fluorescenc
(S.E., 8 mice, *P<0.05, **P<0.001). From reference [60].dextrans. Interestingly, slowed ECS diffusion preceded electro-
encephalographic seizure activity. Diffusion of FITC-dextrans
was significantly accelerated in AQP4 null mice, suggesting an
expanded ECS. In follow-up studies, cortical surface photo-
bleaching was used to demonstrate accelerated macromolecule
diffusion in the expanded ECS in vasogenic edema [58]. We
recently extended this approach to quantify anisotropic diffusion
in spinal cord and brain by ‘elliptical photobleaching’ in which
bleaching was done with an elliptical laser spot (produced by
cylindrical optics) [59]; the contribution of ECS geometry vs.
matrix composition in slowing macromolecular diffusion was
estimated for the first time.
We recently obtained direct in vivo evidence for impaired K+
reuptake from the ECS in AQP4 deficiency. A long-wavelength
K+-sensing fluorescent indicator, TAC-Red (Fig. 7A), was
synthesized, which consisted of a triazacryptand K+ ionophore
coupled to a 3,6-bis(dimethylamino) xanthylium chromophore
[60]. As shown in Fig. 7B, TAC-Red fluorescence increased by
∼15-fold with increasing K+ in the range 0–40 mM, and had
little sensitivity to Na+ or to pH in the range 6–8. More than
90% of the fluorescence increase in response to an increase in
[K+] occurred in under 1 ms. The ECS of mouse brain surface
was stained with TAC-Red by exposing the intact dura (after
craniectomy) for 5 min to aCSF containing TAC-Red. The
TAC-red-stained brain cortex was brightly red fluorescent, with
fairly uniform parenchymal staining. A pin prick model of cor-
tical spreading depression produced propagating K+ waves at
the cortical surface. Some frames of a video are shown (in
pseudocolor) in Fig. 7C, showing a wave of increasing K+. (A) Chemical structure of TAC-Red. (B) Titration of TAC-Red showing serial
of brain cortex at indicated times after initiation of cortical spreading depression
nsities scaled as black–blue–red–yellow–white. (D) Time course of TAC-Red
rent mouse) following initiation of spreading depression. (E) Half-times (t1/2) for
e. Each point is the average (±S.E.M.) from twelve different locations per mouse
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pared the kinetics and propagation velocity of K+ waves in
wildtype vs. AQP4 null mice. Fig. 7D shows broader K+ wave
profiles in the AQP4-deficient mice. Fig. 7E summarizes ave-
raged t1/2 values for the increasing (cellular K
+ release) and
decreasing (K+ reuptake) phases of the fluorescence profile.
Though the t1/2 for the fluorescence release phase was slightly
greater in AQP4 null mice, the t1/2 for the reuptake phase was
remarkably greater (57 vs. 32 s, P<0.001), providing evidence
for impaired glial cell K+ uptake from the ECS in AQP4 defi-
ciency. Further work is needed to define quantitatively the roles
of altered ECS volume vs. K+ uptake in the altered neural trans-
duction phenotypes associated with AQP deficiency.
In related work, Puwarawuttipanit et al. studied hippocampal
slices from α-syntrophin-deficient mice, in which membrane
localization of AQP4 is partially reduced [61], and found a
deficit in extracellular K+ clearance following evoked neuronal
activity. In addition, using a hyperthermia model of seizure
induction, they found more of the α-syntrophin-deficient mice
had more severe seizures than wild-type mice [62]. These data
are consistent with the idea that AQP4 and its molecular partners
(e.g. Kir4.1, α-syntrophin, dystrophin) together comprise a
multifunctional ‘unit’ responsible for clearance of K+ and/or
H2O following neural activity.
5. Summary and perspective
Phenotype analysis of AQP4-null mice has confirmed the
involvement of AQP4 in cytotoxic brain edema, and provided
strong evidence for unexpected roles of AQP4 in vasogenic
brain edema, glial cell migration, and neural signal transduction.
AQP4 facilitates clinically important water movement into and
out of the brain in the development and resolution of brain
edema; however, the precise mechanisms of water-salt coupling
in removal of excess brain water across glia limitans remain
unresolved. The phenotype data suggest AQP4 inhibition by
small-molecules or other agents to reduce the accumulation of
excess brain water in cytotoxic edema in stroke and some types
of infections. AQP4 induction/activation is predicted to reduce
brain water accumulation in vasogenic edema in brain tumor,
focal abscess, and hydrocephalus, as well as accelerate the
clearance of excess of brain water during the resolution phase of
stroke and other forms of cytotoxic brain edema. Modulation of
AQP4 expression or function is also predicted to modulate glial
scar formation, which may be of clinical utility in traumatic
injury, tumor and infection. For example, reduced glial scarring
may facilitate axonal growth and access of chemotherapeutic
agents to a lesion. AQP4 expression in high-grade glia-derived
brain tumors may facilitate their local invasiveness, providing a
rationale for AQP4 inhibition in therapy of some glioblastomas.
AQP4 also appears also to be crucial for brain water and ion
homeostasis during rapid neural activity; however, the precise
mechanisms linking AQP4 expression to altered neural signal-
ing remain unclear. Our recent data suggest increased extra-
cellular space volume in AQP4 deficiency and impaired K+
reuptake by AQP4-deficient astrocytes, which may be related to
functionally significant AQP4-K+ channel interactions. Theseizure phenotype data in AQP4-null mice suggest the possi-
bility of AQP4 modulation in epilepsy therapy, though the dual
consequence of AQP4 modulation on seizure threshold and
duration/severity may complicate such therapy. Thus, though
there remain many basic mechanistic questions about the in-
volvement of AQP4 in brain functions, there are exciting pos-
sibilities for AQP4-based therapy in a variety of common
disorders of the central nervous system.References
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